Medicines Company News
Dow, S&P 500 and Nasdaq End at Record Highs on Trade-Deal Hopes, Merger Activity
Stocks finished strong Monday as all three major indexes ended at records, boosted by trade optimism and a wave of merger deals.
Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drug Maker Medicines Co.
Medicines Co. shares hit a record high Monday after the cholesterol drug maker reached a $10 billion takeover deal with Swiss pharmaceutical giant Novartis AG.
Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know
U.S. stock futures rise as trade optimism and a mini-wave of merger deals boosts market sentiment; France's LVMH agrees to buy the U.S. jeweler Tiffany for $16.2 billion; Novartis reaches a deal to buy cholesterol drugmaker Medicines Co. for $9.7 billion; Disney's 'Frozen 2' makes $127 million domestically in its weekend debut.
Dow Futures Extend Gains, Global Stocks Bounce as Trade Optimism Lifts Sentiment
U.S. equity futures jumped higher Monday, pulling all three major benchmarks back towards all-time peaks, as investors added to bets of a near-term trade pact between Washington and Beijing and reacted to a mini-wave of merger deals that boosted market sentiment around the world.
Novartis to Swallow Up The Medicines Company for $9.7 Billion
Novartis said its main target in the buy was The Medicines Company's specialty cholesterol drug inclisiran that performed well in late-stage clinical trials.
Bank of America Lists Companies With Most Mentions of 'Supply Chain'
These companies made the most mentions of "supply chain" in their first-quarter earnings calls.
Crypto Crisis: Struggling Crypto Lender About to Be Acquired by Rival
Crypto firm Nexo is reviewing the assets of lender Vauld with the intent of acquiring the struggling crypto financial services company.
Ford Makes a Major Change
The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.
Stock Market Today - 7/5: Stocks Slide On Recession Fears; Dollar Hits Two-Decade Peak
A brief overnight inversion of the U.S. yield curve, as well as mounting signs of a near-term recession, have stocks on the back foot heading into the holiday-shortened week.